Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 01.11.2024
MAX Automation SE
Company Name:
MAX Automation SE
ISIN:
DE000A2DA588
Reason for the research:
Update
Recommendation:
Buy
from:
01.11.2024
Target price:
EUR 7.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Konstantin Völk
Guidance revision // muted Q3 ahead; chg. est. & PT
Topic: MAX will release its Q3 numbers on [ … ]
Wed, 30.10.2024
Verve Group SE
Company Name:
Verve Group SE
ISIN:
SE0018538068
Reason for the research:
vorläufige Q3-Kennzahlen
Recommendation:
Kaufen
from:
30.10.2024
Target price:
€5,40
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE [ … ]
Wed, 30.10.2024
Flughafen Wien AG
Company Name:
Flughafen Wien AG
ISIN:
AT00000VIE62
Reason for the research:
Update
Recommendation:
Hold
from:
30.10.2024
Target price:
EUR 61.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Q3 preview: strong growth and margins at cruising altitude
FWAG releases Q3 results on 14th November, [ … ]
Wed, 30.10.2024
UBM Development AG
Company Name:
UBM Development AG
ISIN:
AT0000815402
Reason for the research:
Update
Recommendation:
Buy
from:
30.10.2024
Target price:
EUR 27.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Muted Q3 ahead but successful financing and letting
Topic: UBM will release its Q3 report on 28th N [ … ]
Tue, 29.10.2024
Pharming Group NV
Company Name:
Pharming Group NV
ISIN:
NL0010391025
Reason for the research:
Q3/24 results
Recommendation:
Buy
from:
29.10.2024
Target price:
€1.70
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Simon Scholes
First Berlin Equity Research has published a research update on Pharming Group NV (ISIN: NL0010 [ … ]
Tue, 29.10.2024
Knaus Tabbert AG
Company Name:
Knaus Tabbert AG
ISIN:
DE000A2YN504
Reason for the research:
Update
Recommendation:
Kaufen
from:
29.10.2024
Target price:
€54
Target price on sight of:
12 Monate
Last rating change:
-
Analyst:
Ellis Acklin
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) verö [ … ]
Tue, 29.10.2024
q.beyond AG
Company Name:
q.beyond AG
ISIN:
DE0005137004
Reason for the research:
Update
Recommendation:
Buy
from:
29.10.2024
Target price:
EUR 1.10
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Q3 preview: Stable development & improved consulting; chg.
q.beyond will release its Q3 report on Novem [ … ]
Tue, 29.10.2024
CR Energy AG
Company Name:
CR Energy AG
ISIN:
DE000A2GS625
Reason for the research:
Update
Recommendation:
Buy
from:
29.10.2024
Target price:
EUR 12.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Philipp Sennewald
Positive operating development in H1
Topic: CR Energy released its H1 report, which shows a strong operat [ … ]
Mon, 28.10.2024
Cardiol Therapeutics Inc
Company Name:
Cardiol Therapeutics Inc
ISIN:
CA14161Y2006
Reason for the research:
Update
Recommendation:
Buy
from:
28.10.2024
Target price:
USD8.50
Target price on sight of:
12 months
Last rating change:
-
Analyst:
Christian Orquera
First Berlin Equity Research has published a research update on Cardiol Therapeutics Inc. (ISI [ … ]
Fri, 25.10.2024
ZEAL Network SE
Company Name:
ZEAL Network SE
ISIN:
DE000ZEAL241
Reason for the research:
Update
Recommendation:
Buy
from:
25.10.2024
Target price:
EUR 57.00
Target price on sight of:
12 months
Last rating change:
Analyst:
Henry Wendisch
Guidance hike confirms strong momentum; chg. est & PT
Yesterday after the bell, ZEAL released an ad-h [ … ]
